Clinical Trial Update: Biomarkers for Cardiovascular Disease

View source ↗

Summary

An update on a completed NHLBI-sponsored clinical trial investigating biomarkers for cardiovascular disease, with a focus on coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Coronary Artery Disease | Status: COMPLETED